Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo

NCT04549376 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID19

Interventions

DRUG: Povidone-Iodine 0.4% NI
DRUG: Povidone-Iodine 0.5% NI
DRUG: Povidone-Iodine 0.6% NI
DRUG: Povidone-Iodine 0.5% NS
DRUG: Povidone-Iodine 0.6% NS
OTHER: Placebo comparator: DW-NI
OTHER: Placebo comparator: DW-NS

Sponsor

DR. MALA KHAN

Collaborators

[object Object]